Discuss your vaccination schedule with your gastroenterologist and primary care provider
It has been found to address complex and chronic foot and ankle conditions, such as plantar fasciitis, Achilles tendinopathy, diabetic neuropathy, post-surgical foot and ankle repair, and ligament and tendon injuries, and is especially effective when used with platelet-rich plasma, stem cell therapies, or biologics
A healthcare provider will recommend the best dose based on individual needs
Collagen and fibroblast activity: In animal studies, BPC-157 has been associated with altered fibroblast activity and collagen deposition patterns
It raises questions for post-operative vascular surgery and disorders of venous return
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase